Comparative Cardiovascular Safety and Exploratory Bleeding Outcomes of Ibrutinib, Acalabrutinib, and Zanubrutinib in Mantle Cell Lymphoma: A Propensity Score‐Matched Real‐World Analysis

Anna Homeniuk, Amrit Sandhu, Leena Abdalla, Anas Atrash

Open source

DOI
10.1002/cam4.72111
Published
2026-08
Container
Cancer Medicine
Publisher
Wiley
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/cam4.72111,
  title = {Comparative Cardiovascular Safety and Exploratory Bleeding Outcomes of Ibrutinib, Acalabrutinib, and Zanubrutinib in Mantle Cell Lymphoma: A Propensity Score‐Matched Real‐World Analysis},
  author = {Anna Homeniuk and Amrit Sandhu and Leena Abdalla and Anas Atrash},
  year = {2026},
  journal = {Cancer Medicine},
  doi = {10.1002/cam4.72111},
  url = {https://doi.org/10.1002/cam4.72111}
}

RIS

TY  - JOUR
TI  - Comparative Cardiovascular Safety and Exploratory Bleeding Outcomes of Ibrutinib, Acalabrutinib, and Zanubrutinib in Mantle Cell Lymphoma: A Propensity Score‐Matched Real‐World Analysis
AU  - Anna Homeniuk
AU  - Amrit Sandhu
AU  - Leena Abdalla
AU  - Anas Atrash
PY  - 2026
JO  - Cancer Medicine
DO  - 10.1002/cam4.72111
UR  - https://doi.org/10.1002/cam4.72111
ER  - 

APA

Homeniuk, A., Sandhu, A., Abdalla, L., & Atrash, A. (2026). Comparative Cardiovascular Safety and Exploratory Bleeding Outcomes of Ibrutinib, Acalabrutinib, and Zanubrutinib in Mantle Cell Lymphoma: A Propensity Score‐Matched Real‐World Analysis. Cancer Medicine. https://doi.org/10.1002/cam4.72111

Source records